Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer

By sjmartinez • February 26, 2024

Edwards DM, Sankar K, Alseri A, Jiang R, Schipper M, Miller S, Dess K, Strohbehn GW, Elliott DA, Moghanaki D, Ramnath N, Green MD, Bryant AK. Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys. 2024 Mar 15;118(4):963-970. doi: 10.1016/j.ijrobp.2023.09.050. Epub 2023 Oct 2. PMID: 37793573.

Tags: Cedars Sinai DoM, Hematology/Oncology, Publications

Elevated serum levels of GPX4, NDUFS4, PRDX5, and TXNRD2 as predictive biomarkers for castration resistance in prostate cancer patients: an exploratory study

Wang R, Wang S, Mi Y, Huang T, Wang J, Ni J, Wang J, Yin J, Li M, Ran X, Fan S, Sun Q, Tan[...]

Observational study of sudden cardiac arrest risk (OSCAR): Rationale and design of an electronic health records cohort

Reinier K, Chugh HS, Uy-Evanado A, Heckard E, Mathias M, Bosson N, Calsavara VF, Slomka PJ, Elashoff DA, Bui AAT, Chugh SS. Observational study of[...]

Health System, Community-Based, or Usual Dementia Care for Persons With Dementia and Caregivers: The D-CARE Randomized Clinical Trial

Reuben DB, Gill TM, Stevens A, Williamson J, Volpi E, Lichtenstein M, Jennings LA, Galloway R, Summapund J, Araujo K, Bass D, Weitzman L, Tan[...]